{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-003779","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.388203+00:00","generated_at":"2026-06-06T18:55:58.574359+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"AIM ImmunoTech furnishes supplemental data deck on pancreatic cancer Early Access Program","bullets":["Deck titled 'Pancreatic Cancer Early Access Program Supplemental Data Q1 2024' furnished as Exhibit 99.1.","Data posted on the 'Investors' section of the company's website.","No specific clinical results or financial figures disclosed in the 8-K filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-003779","json":"https://secwatch.observer/filing/0001493152-24-003779.json","markdown":"https://secwatch.observer/filing/0001493152-24-003779.md","text":"https://secwatch.observer/filing/0001493152-24-003779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315224003779/0001493152-24-003779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315224003779/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T18:55:58.574359+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}